Added to YB: 2026-01-19
Pitch date: 2025-11-17
NKTR [bullish]
Nektar Therapeutics
-36.34%
current return
Author Info
No bio for this author
Company Info
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.
Market Cap
$734.1M
Pitch Price
$59.19
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.01
P/E
-4.57
EV/Sales
10.08
Sector
Pharmaceuticals
Category
growth
Nektar Therapeutics - $NKTR
NKTR: Derisked atopic dermatitis drug targeting $1.5-2.5B peak sales (~$2-2.5B NPV) backstops $1.2B market cap. Alopecia Ph2 readout end-2025 is free upside - mechanism sound, Reddit posts suggest efficacy in trial patients with injection site reactions. LLY acquisition rumors circulating.
Read full article (7 min)